医学
反流(循环)
心脏病学
射血分数
内科学
心力衰竭
作者
Rebecca T. Hahn,JoAnn Lindenfeld,Michael Böhm,Frank Edelmann,Lars H. Lund,Philip Lurz,Marco Metra,Ryan J. Tedford,Javed Butler,Barry A. Borlaug
标识
DOI:10.1016/j.jacc.2024.04.047
摘要
Heart failure with preserved ejection fraction (HFpEF) is associated with high morbidity and mortality. Important risk factors for the development of HFpEF are similar to risk factors for the progression of tricuspid regurgitation (TR), and both conditions frequently coexist and thus is a distinct phenotype or a marker for advanced HF. Many patients with severe, symptomatic atrial secondary TR have been enrolled in current transcatheter device trials, and may represent patients at an advanced stage of HFpEF. Management of HFpEF thus may affect the pathophysiology of TR, and the physiologic changes that occur following transcatheter treatment of TR, may also impact symptoms and outcomes in patients with HFpEF. This review discusses these issues and suggests possible management strategies for these patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI